Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov identifier: NCT02492568.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer | Synapse